Amjevita Injection
Product Images NDC 84612-482

Product Visual Gallery

This gallery contains 63 technical images submitted to the FDA as part of the official labeling for Amjevita (NDC 84612-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvaila Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amjevita 01)

This text provides information about the percentage of ACR 20 responders over time for two groups: one receiving a certain dosage of a medication every other week and the other receiving a placebo. The data is presented up to 48 weeks.*

FDA Label Image

Figure 2 (Amjevita 02)

This is a data comparison chart showing the response rates of a placebo group (N=107) versus an adalimumab group (N=208) over a period of 26 weeks. The x-axis represents time in weeks, while the y-axis likely indicates the response rate.*

FDA Label Image

Figure 3 (Amjevita 03)

This is a chart showing the treatment failure rate for both placebo and Adalimumab over a 20-month period. The failure rates are displayed as percentages for each month for each type of treatment. The data indicates a decrease in failure rate over time for Adalimumab compared to placebo.*

FDA Label Image

Figure 3 (Amjevita 04)

This is not readable.*

FDA Label Image

Image (Amjevita 05)

This is a description of parts for a syringe. It includes a plunger rod, expiration date, syringe body, needle cap, finger grip, and medicine. The parts are essential for the proper operation of a syringe for medical purposes.*

FDA Label Image

Image (Amjevita 06)

FDA Label Image

Image (Amjevita 07)

FDA Label Image

Image (Amjevita 08)

FDA Label Image

Image (Amjevita 09)

This text provides a simple and practical instruction to "Refrigerate in carton until ready to use". This guidance suggests keeping the item inside its packaging in the refrigerator until you are prepared to use it. This can help maintain the freshness and quality of the product until it is needed.*

FDA Label Image

Image (Amjevita 10)

FDA Label Image

Image (Amjevita 11)

FDA Label Image

Image (Amjevita 12)

FDA Label Image

Image (Amjevita 13)

This is a list of medical supplies that may be used for first aid or minor medical procedures. It includes an alcohol wipe for cleaning, an adhesive bandage for covering wounds, a cotton ball or sharps gauze pad for applying pressure or cleaning wounds, and a disposal container for safe disposal of sharp objects. These supplies are commonly found in first aid kits and medical facilities.*

FDA Label Image

Image (Amjevita 14)

FDA Label Image

Image (Amjevita 15)

FDA Label Image

Image (Amjevita 16)

FDA Label Image

Image (Amjevita 17)

FDA Label Image

Image (Amjevita 18)

FDA Label Image

Image (Amjevita 19)

FDA Label Image

Image (Amjevita 20)

FDA Label Image

Image (Amjevita 21)

This text is a brief instruction for medical personnel or individuals administering injections. It suggests pinching the skin at the injection site before administering the injection, which can help reduce pain and ensure proper needle insertion.*

FDA Label Image

Image (Amjevita 22)

FDA Label Image

Image (Amjevita 23)

FDA Label Image

Image (Amjevita 24)

FDA Label Image

Image (Amjevita 25)

FDA Label Image

Image (Amjevita 26)

This text appears to be describing the features of a medication injector pen. It includes information about the light blue start button, expiration date, plunger, window, cream safety guard, yellow cap, and the medication dosage of 40 mg/0.4 mL. The text seems to provide guidance on how to use the injector pen.*

FDA Label Image

Image (Amjevita 27)

This text provides a recommendation to refrigerate a product in its carton until it is ready to be used. It suggests storing the item in the packaging until it is needed.*

FDA Label Image

Image (Amjevita 28)

FDA Label Image

Image (Amjevita 29)

FDA Label Image

Image (Amjevita 30)

FDA Label Image

Image (Amjevita 31)

FDA Label Image

Image (Amjevita 32)

This is a list of medical supplies: Sharps disposal container, alcohol wipe, adhesive bandage, cotton ball or gauze pad. These items are essential for first aid and wound care.*

FDA Label Image

Image (Amjevita 33)

FDA Label Image

Image (Amjevita 34)

FDA Label Image

Image (Amjevita 35)

FDA Label Image

Image (Amjevita 36)

This text indicates a requirement for a window to be visible in a software interface or application. This could be a critical usability requirement for ensuring that users can interact with the window easily.*

FDA Label Image

Image (Amjevita 37)

This text mentions "PINCH skin at injection site," implying that it is recommending pinching the skin at the injection site before administering an injection. This technique can help reduce pain and discomfort during the injection process.*

FDA Label Image

Image (Amjevita 38)

FDA Label Image

Image (Amjevita 39)

FDA Label Image

Image (Amjevita 40)

FDA Label Image

Image (Amjevita 41)

FDA Label Image

Image (Amjevita 42)

FDA Label Image

Image (Amjevita 43)

This text is a description of a medication product. It provides information about the expiration date, dosage concentration (80 mg/0.8 mL), the presence of a cream safety guard with a needle inside, a light blue start button, the plunger which may be visible in a window with varying locations, and a yellow cap.*

FDA Label Image

Image (Amjevita 44)

This text provides a simple instruction to refrigerate the item in the carton until ready to use. It suggests following this guidance to maintain the product's freshness and quality.*

FDA Label Image

Image (Amjevita 45)

FDA Label Image

Image (Amjevita 46)

FDA Label Image

Image (Amjevita 47)

FDA Label Image

Image (Amjevita 48)

FDA Label Image

Image (Amjevita 49)

This is a list of basic first aid supplies that may be needed in case of small cuts or injuries. It includes alcohol wipes for disinfection, adhesive bandages for covering wounds, and cotton balls or gauze pads for applying medication or cleaning wounds. These items are essential for a basic first aid kit.*

FDA Label Image

Image (Amjevita 50)

FDA Label Image

Image (Amjevita 51)

FDA Label Image

Image (Amjevita 52)

FDA Label Image

Image (Amjevita 53)

This text is not readable.*

FDA Label Image

Image (Amjevita 54)

This advice instructs to pinch the skin at the injection site, possibly to make injecting easier or less painful.*

FDA Label Image

Image (Amjevita 55)

FDA Label Image

Image (Amjevita 56)

FDA Label Image

Image (Amjevita 57)

FDA Label Image

Image (Amjevita 58)

FDA Label Image

Image (Amjevita 59)

FDA Label Image

Principal Display Panel (20 mg/0.2 mL Syringe Carton)

This is a detailed description of the medication Amjevita® (adalimumab-atto). It is an injection intended for subcutaneous use only. The solution is sterile with no preservative and should be stored between 36°F to 46°F. It should not be frozen, reused, or shaken, and must be protected from light. The medication is made with natural rubber latex. Each prefilled syringe contains 20mg/0.2mL for single-dose use. It is suitable for pediatric patients weighing between 15kg to <45kg and should be refrigerated until ready to use. Patients should consult the enclosed Medication Guide for instructions.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe Carton)

This document appears to be a medication guide for Amjevita (adalimumab-atto), which is an injection used subcutaneously. The medication is provided in single-dose prefilled syringes containing 40mg per 0.4mL. It is advised to store the sterile solution refrigerated at 2°C to 8°C and not to freeze, reuse, or shake the syringe. The enclosed medication guide is essential for each patient.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Autoinjector Carton)

FDA Label Image

Principal Display Panel (80 mg/0.8 mL Autoinjector Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.